Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Volume Increase – Here’s Why

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) saw strong trading volume on Tuesday. 3,597,782 shares changed hands during mid-day trading, an increase of 403% from the previous session’s volume of 715,173 shares. The stock last traded at $21.2810 and had previously closed at $21.94.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on FMS. Sanford C. Bernstein lifted their target price on shares of Fresenius Medical Care AG & Co. KGaA from $25.50 to $25.80 and gave the company a “market perform” rating in a research note on Thursday, August 6th. Berenberg Bank set a $24.00 price target on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, September 29th. Zacks Research lowered Fresenius Medical Care AG & Co. KGaA from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. BNP Paribas Exane cut Fresenius Medical Care AG & Co. KGaA from a “neutral” rating to an “underperform” rating and set a $19.90 price objective for the company. in a research report on Tuesday, July 28th. Finally, Weiss Ratings raised Fresenius Medical Care AG & Co. KGaA from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, October 8th. Seven research analysts have rated the stock with a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce” and an average target price of $23.42.

Fresenius Medical Care AG & Co. KGaA Price Performance

The company has a debt-to-equity ratio of 0.43, a current ratio of 1.07 and a quick ratio of 0.75. The stock has a market capitalization of $11.50 billion, a price-to-earnings ratio of 11.09, a PEG ratio of 4.10 and a beta of 0.74. The stock’s 50 day simple moving average is $22.60 and its 200-day simple moving average is $22.88.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last announced its quarterly earnings results on Monday, August 3rd. The company reported $0.66 EPS for the quarter, topping the consensus estimate of $0.62 by $0.04. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a return on equity of 9.28%. The company had revenue of $5.55 billion for the quarter, compared to analyst estimates of $5.48 billion. On average, analysts expect that Fresenius Medical Care AG & Co. KGaA will post 2.25 EPS for the current fiscal year.

Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of large investors have recently bought and sold shares of FMS. Mather Group LLC. boosted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 838.0% during the 3rd quarter. Mather Group LLC. now owns 1,407 shares of the company’s stock worth $31,000 after acquiring an additional 1,257 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 39.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,915 shares of the company’s stock valued at $43,000 after acquiring an additional 538 shares during the last quarter. QRG Capital Management Inc. raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 15.7% in the 2nd quarter. QRG Capital Management Inc. now owns 89,267 shares of the company’s stock valued at $2,018,000 after acquiring an additional 12,139 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Fresenius Medical Care AG & Co. KGaA by 95.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 39,527 shares of the company’s stock valued at $894,000 after acquiring an additional 19,252 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in Fresenius Medical Care AG & Co. KGaA by 96.0% in the 2nd quarter. Tidal Investments LLC now owns 99,790 shares of the company’s stock worth $2,256,000 after purchasing an additional 48,885 shares during the last quarter. 8.37% of the stock is currently owned by institutional investors.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is a Germany-based health care company focused on the treatment of chronic kidney failure. The company provides dialysis care for patients with end-stage renal disease through a network of outpatient dialysis clinics and other health care facilities.

In addition to operating dialysis centers, Fresenius Medical Care develops and supplies products used in dialysis treatment. Its portfolio includes hemodialysis machines, dialyzers, dialysis solutions, bloodlines, and related medical devices and services.